Dermapharm Holding SE
OTC:DMPHF
Wall Street
Price Targets
DMPHF Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for
DMPHF
is 45.74 USD
with a low forecast of 36.67 USD and a high forecast of 53.81 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DMPHF's stock price target?
Price Target
45.74
USD
According to Wall Street analysts, the average 1-year price target for
DMPHF
is 45.74 USD
with a low forecast of 36.67 USD and a high forecast of 53.81 USD.
What is Dermapharm Holding SE's Revenue forecast?
Projected CAGR
3%
For the last 9 years the
compound annual growth rate for
Dermapharm Holding SE's revenue is
13%.
The projected
CAGR
for the next 4 years is
3%.
What is Dermapharm Holding SE's Operating Income forecast?
Projected CAGR
7%
For the last 9 years the
compound annual growth rate for
Dermapharm Holding SE's operating income is
14%.
The projected
CAGR
for the next 4 years is
7%.
What is Dermapharm Holding SE's Net Income forecast?
Projected CAGR
14%
For the last 9 years the
compound annual growth rate for
Dermapharm Holding SE's net income is
28%.
The projected
CAGR
for the next 4 years is
14%.
